Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

59,000

Employees59,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

59,000

Employees59,000

BSX Key Statistics

Market cap

63.13B

Market cap63.13B

Price-Earnings ratio

17.81

Price-Earnings ratio17.81

Dividend yield

—

Dividend yield—

Average volume

22.95M

Average volume22.95M

High today

$43.85

High today$43.85

Low today

$42.95

Low today$42.95

Open price

$43.25

Open price$43.25

Volume

32.57M

Volume32.57M

52 Week high

$105.65

52 Week high$105.65

52 Week low

$42.20

52 Week low$42.20

Stock Snapshot

The current Boston Scientific(BSX) stock price is $43.55, with a market capitalization of 63.13B. The stock trades at a price-to-earnings (P/E) ratio of 17.81.

On 2026-09-18, Boston Scientific(BSX) stock traded between a low of $42.95 and a high of $43.85. Shares are currently priced at $43.55, which is +1.4% above the low and -0.7% below the high.

The Boston Scientific(BSX)'s current trading volume is 32.57M, compared to an average daily volume of 22.95M.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $105.65 at its peak.

BSX News

TipRanks 4h

Analyst Maintains Buy on Boston Scientific, Viewing Cyberattack Impact as Short-Lived Despite Trimmed Near-Term Forecasts

Analyst Josh Jennings of TD Cowen maintained a Buy rating on Boston Scientific, with a price target of $56.00. Josh Jennings has given his Buy rating due to a c...

Seeking Alpha 19h

Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout

Citi downgraded Boston Scientific (BSX) to Neutral from Buy, saying that it is still contending with the aftermath of an August cyberattack, as well as increase...

Zacks 22h

BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now? - Zacks Investment Research

...

Analyst ratings

82%

of 33 ratings

Buy

81.8%

Hold

18.2%

Sell

More BSX News

TipRanks 1d

Citi downgrades Boston Scientific to Neutral on uncertain recovery

Citi downgraded Boston Scientific (BSX) to Neutral from Buy with a price target of $50, down from $57. The company faces a “more mature” U.S. pulsed field ablat...

Simply Wall St 3d

Boston Scientific Faces Cyberattack And Recall Fallout, Is The Sell Off Overdone?

Advertisement Why Boston Scientific stock is in focus now Boston Scientific (BSX) is back on many watchlists after an August cyberattack disrupted manufacturi...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Intuit

Stryker

NRG Energy

Waystar Holding Corp.

Pampa Energia

Axis Capital Holders

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.